Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice

Laboratory Investigation

Volumn 76, Issue 5, 1997, Pages 691-701

  Huber, Sally A ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; COXSACKIE VIRUS; HEART DILATATION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS MYOCARDITIS;

ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HEART VENTRICLES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, INBRED MRL LPR; MYOCARDITIS; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 0030923024     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Arai M, Alpert NR, MacLennan DH, Barton P, and Periasamy M (1993). Alterations in sarcoplasmic reticulum gene expression in human heart failure: A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72:463-469.
2. Arnal JF, Delorme G, Dubourg O, Pussard E, Beauchet A, Jondeau G, Sahraie H, Bordeaux A, and Bourdarias JP (1992). Correlations between plasma concentrations of atrial natriuretic factor and right ventricular function in patients with severe cardiac failure. Archives des Maladies du Coeur et des Vaisseaux 85:45-52.
3. Arola A, Kalimo H, Ruuskanen O, and Hijypia T (1995). Experimental myocarditis induced by two different coxsackievirus B3 variants: Aspects of pathogenesis and comparison of diagnostic methods. J Med Virol 47:251-259.
4. Barry WH (1994). Mechanisms of immune-mediated myocyte injury. Circulation 89:2421-2426.
5. Bowles NE, Richardson P, Olsen EGJ, and Archard LC (1986). Detection of coxsackie B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1:1120-1123.
6. Chien KR, Knowlton KU, Zu H, and Chien S (1991). Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiological response. FASEB J 5:3037-3046.
7. Cohen JJ, Duke RC, Fadok VA, and Sellins KS (1992). Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293.
8. Farrar JD and Street NE (1995). A synthestic standard DNA construct for the use in quantification of murine cytokine mRNA molecules. Mol Immunol 32:991-1000.
9. Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, and Crawley R (1995). Molecular mimicry, anti-coxsackievirus B3 monoclonal neutralizing antibodies, and myocarditis. J Immunol 154:2983-2995.
10. Gavrieli Y, Sherman Y, and Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
11. Gottlieb RA, Burleson KO, Kloner RA, Bablor BM, and Engler RL (1994). Reperfusion injury induces apoptosis in rabbit cariomyocytes. J Clin Invest 94:1621-1628.
12. Hamrell BB, Huber SA, and Leslie KO (1994). Reduced unloaded sarcomere shortening velocity and a shift to a slower myosin isoform in acute murine coxsackievirus myocarditis. Circ Res 75:462-472.
13. Hamrell BB, Huber SA, and Leslie KO (1995). Depressed unloaded sarcomere shortening velocity in acute coxsackievirus myocarditis: Myocardial remodeling in the absence of necrosis or hypertrophy. Eur Heart J 16(Suppl O):31-35.
14. Henke A, Huber S, Stelzner A, and Whitton JL (1995). The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 69:6720-6728.
15. Holder E, Mitmaker B, Alpert L, and Chalifour L (1995). Morphometric and muscle gene expression in hypertrophied hearts from polyomavirus large T antigen transgenic mice. Am J Physiol 269(Pt 2):H86-H95.
16. Huber SA, Hamrell BB, and Knowlton KU (1996a). Lessons from animal models of viral myocarditis. In: Schultheiss H-P and Schwimmbeck P, editors. The role of immune mechanisms in heart disease. Berlin: Springer-Verlag, 35-43.
17. Huber SA and Lodge PA (1984). Coxsackievirus myocarditis in mice: Evidence for an autoimmune disease. Am J Pathol 116:21-29.
18. Huber SA and Lodge PA (1986). Coxsackievirus B3 myocarditis: Identification of different pathogenic mechanisms in DBA/2 and BALB/c mice. Am J Pathol 122:284-291.
19. Huber SA, Moraska A, and Cunningham M (1994). Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 variants selected with monoclonal antibodies to group A streptococci. Proc Natl Acad Sci USA 91:5543-5547.
20. Huber SA, Mortensen A, and Moulton G. (1996b). Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the γδ+ T-cell receptor. J Virol 70:3039-3044.
21. Hufnagel G, Chapman N, and Tracy S (1995). A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome. Eur Heart J 16(Suppl O):18-19.
22. James TN (1994). Normal and abnormal consequences of apoptosis in the human heart: From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 90:556-573.
23. James TN, Nichols MM, Sapire DW, DiParre PL, and Lopez SM (1996). Complete heart block and fatal right ventricular failure in an infant. Circulation 93:1588-1600.
24. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P (1996). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74:86-107.
25. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed, JC, Quaini F, Sonnenblick EH, and Anversa P (1995). Programmed cell death and the expression of the protooncogene Bcl-2 in myocyte during postnatal maturation of the heart. Exp Cell Res 219:110-121.
26. Kandolf R and Hofschneider PH (1989). Viral heart diseases. Springer Semin Immunopathol 11:1-13.
27. Katz AM (1995). The cardiomyopathy of overload: An unnatural growth response. Eur Heart J 16(Suppl O):110-114.
28. Kawano H, Okada R, Kawano Y, Sueyoshi N, and Shirai T (1994). Apoptosis in acute and chronic myocarditis. Jpn Heart J 35:745-750.
29. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, and Rose NR (1992). Interleukin 1 or tumor necrosis factor can promote coxsackie B3 induced myocarditis in resistant B10. A mice. J Exp Med 175:1123-1129.
30. Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, and Diamond B (1995). Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med 181:1123-1131.
31. Liguori A, Di Gregorio F, Napoli C, D'Armiento FP, Posca T, Di Benedetto A, Di Ieso N, Di Paolo E, and Ferrara A (1994). Atrial natriuretic factor and sympathetic activation in human heart failure. Rivista Europea Per Le Scienze Mediche e Farmacologiche 16:61-67.
32. Lodge PA, Herzum M, Olszewski J, and Huber SA (1987). Coxsackievirus B3 myocarditis: Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 128:455-463.
33. Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, and Herskowitz A (1996). Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest 97:1837-1843.
34. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, and Fontaine G (1996). Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med 335:1190-1196.
35. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, and Kandolf R (1993). Direct myocardial injury by enterovirus: A central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68:159-169.
36. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, and Khaw B-A (1996). Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189.
37. Neumann DA, Rose NR, Ansari AA, and Herskowitz A (1994). Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol 152:343-350.
38. Ogasawara S, Morimoto S, and Sekiguchi M (1994). Prognosis of dilated cardiomyopathy employing a prognostic score. In: Sekiguchi M and Richardson PJ, editors. Prognosis and treatments of cardiomyopathies and myocarditis. Tokyo: University of Tokyo Press, 135-139.
39. Olsen EGJ (1985). What is myocarditis? In: Sekiguchi M, Olsen EGF, and Goodwin JF, editors. Myocarditis and related disorders. Tokyo: Springer-Verlag, 1-3.
40. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, and Nagata S (1995). Expression of the Fas ligand in cells of the T cell lineage. J Immunol 154:3806-3813.
41. Tanaka M, Ito H, Adachi S, Nishikawa T, Kasajima T, Marumo F, and Hiroe M (1994). Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiocytes. Circ Res 75:426-433.
42. Van Houten N and Budd RC (1992). Accelerated programmed cell death on MRL-lpr/lpr T lymphocytes. J Immunol 149:2513-2517.
43. Van Houten N, Bouchard PE, Moraska A, and Huber SA (1991). Selection of an attenuated coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. J Virol 65:1286-1290.
44. Wolfgram LJ, Beisel KW, Herskowitz A, and Rose NR (1986). Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol 136:1846-1852.
45. Woodruff JF (1980). Viral myocarditis: A review. Am J Pathol 101:425-466.
46. Young LH, Joag SV, Zheng LM, Lee CP, Lee YS, and Young JD (1990). Perforin-mediated myocardial damage in acute myocarditis. Lancet 336:1019-1021.